Posted by Michael Wonder on 23 Mar 2021
AstraZeneca vaccine trial data questions raised by US drug agency
23 March 2021 - Promising results announced on Monday from AstraZeneca’s American vaccine trials may have relied on an incomplete view of efficacy data, according to a statement released by the US government’s National Institute of Allergy and Infectious Diseases.
The statement from the peak agency, helmed by Dr Anthony Fauci, is a setback for the company’s hopes of US authorisation for emergency use.
